📐 HR 0.68 = a 32% relative risk reduction in recurrence at any given moment during follow-up.
That sounds like a large benefit.
But the absolute numbers tell a different story:
BCG alone: 81.6% disease-free at 2 years
BCG + durvalumab: 86.5% disease-free at 2 years
Absolute difference: ~5%
Since BCG already works well, a big relative reduction maps to a modest absolute gain. @MaxKates@UrogerliMD@JoshMeeks
Congratulations to Samuel Carbunaru and Vyom Sawhney, our stellar NYU Langone residents, on your awards for original research presented at the @NYSAUA Valentine essay contest last night! 🎉👍🏅
I’ve been trying maturing stoma first before ureter anastomosis for intracorporeal IC like I used to do in open. Easier to place diversion stents. Also no question about any potential tension on ureter anastomosis after maturing the stoma @lee_c_zhao@WVU_Urology@IFRUEUrol
The standard of care for MIBC will now include perioperative EVP for both cisplatin eligible and ineligible #BladderCancer pts. The EV304 study presented today @MattGalsky shows an improvement in EFS (HR 0.53) and OS (HR 0.65) for EVP over GC. @ASCO#GU26
In 1980, DeBakey operated on the Shah of Iran. He declares success. Soon, the patient is dead. Reoperation is psychologically brutal: how bias delay truth & what might save us from the same trap. https://t.co/5nZdjJEcmA #MedTwitter#Surgery#MedEd
Huge congrats to the bossman on receiving the 2025 Ferdinand C. Valentine Medal — a well-deserved honor for a true legend in the field. Proud to see him standing among giants (and holding his own). @NYSAUA@AmerUrological@nyugrossman@NYUUrology@nyulangone
Congratulations to Walter Roper for 1st place poster and Vyom Sawhney for 3rd place podium at the NY Section AUA Valentine Research contest! What a day for NYU Langone!
Attention med students‼️ We are offering a one-year paid research fellowship! This program is targeted towards 3rd & 4th year students or those who have recently gone unmatched in the Urology Match process. Click the link below for more details⬇️
https://t.co/7Dypx6Wf7C
Looking for applicants interested in a one or two yr urologic oncology fellowship @NYUUrology. High volume of robotic surgery, PCa focal therapy, imaging, and multidisciplinary care. Formal research training/masters degree in the 2 yr model. If interested, DM me!